Top Markets
#1 ICON ICON +156.44%
#2 ZetaChain ZetaChain +47.92%
#3 Four Four +39.72%
#4 Phala Phala +34.53%
#5 Chia Chia +33.77%
#6 Mubarak Mubarak +32.15%
#7 Nano Nano +27.88%
#8 SODAX SODAX +26.10%
#9 Bitway Bitway +24.95%
#10 PumpMeme PumpMeme +23.83%
Coin of the day
ICON ICON
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Classifica tra le azioni #827
Zoetis Inc. stands as a global leader in animal health, focusing on the... Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
Prezzo delle azioni
$71.46
Capitalizzazione di mercato
$29.96B
Variazione (1 giorno)
-0.04%
Variazione (1 anno)
-51.01%
Paese
US
Scambia Zoetis Inc. (ZTS)

Categoria

Healthcare
Ricavi di Zoetis Inc. (ZTS)
Ricavi nel Jun 2026 TTM: $9.52B
Secondo gli ultimi rapporti finanziari di Zoetis Inc., i ricavi attuali dell'azienda (TTM) sono pari a $9.52B. Nel 2024, l'azienda ha registrato ricavi di $9.26B un aumento rispetto a i ricavi dell'anno 2023, che erano pari a $8.54B. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Zoetis Inc. da 2009 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
2026 (TTM) $9.52B 0.53%
2025 $9.47B 2.28%
2024 $9.26B 8.33%
2023 $8.54B 5.74%
2022 $8.08B 3.91%
2021 $7.78B 16.49%
2020 $6.68B 6.63%
2019 $6.26B 7.47%
2018 $5.83B 9.76%
2017 $5.31B 8.57%
2016 $4.89B 2.58%
2015 $4.77B -0.42%
2014 $4.79B 4.91%
2013 $4.56B 5.19%
2012 $4.34B 2.43%
2011 $4.23B 18.17%
2010 $3.58B 29.78%
2009 $2.76B 0.00%
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $79.67B 737.09%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $97.93B 928.99%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $64.39B 576.54%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $77.52B 714.53%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $66.40B 597.70%
US